ArticleThe American journal of pathology2015

Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular Permeability.

Nori Nagai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.